Table 7.
Detailed analysis of selected drugs with spike glycoprotein RBD model involving significant interactions.
| Sr.No. | Drug | Significant spike RBD model interacting residues | Bond Type | Bond Length (in Å) | Interacting residues of Actual spike Glycoprotein |
Precise Loop Interactions |
Contact residues of the SARS-CoV-2 RBD–ACE2 | Cysteine residue interactions | |
|---|---|---|---|---|---|---|---|---|---|
| RBD (319–541) | RBM (437–508) | ||||||||
| 1 | Tenofovir | W436 | Conventional Hydrogen bond | 2.62 | Yes | No | No | No | No |
| F342 | Carbon Hydrogen bond | 3.30 | Yes | No | No | No | No | ||
| W436 | Electrostatic (pi-anion) | 3.48 | Yes | No | No | No | No | ||
| L441* | Hydrophobic (pi-sigma) | 3.58 | Yes | Yes | 2 g | No | No | ||
| W436 | Hydrophobic (pi-sigma) | 3.80 | Yes | No | No | No | No | ||
| 2 | Eugenol | E471 | Carbon Hydrogen bond | 3.30 | Yes | Yes | 3a | No | No |
| E471 | Carbon Hydrogen bond | 3.29 | Yes | Yes | 3a | No | No | ||
| D467 | Electrostatic (pi-anion) | 3.74 | Yes | Yes | No | No | No | ||
| K458 | Hydrophobic (pi-sigma) | 3.81 | Yes | Yes | 2 g | No | No | ||
| 3 | Allicin | E471 | Electrostatic interaction | 3.78 | Yes | Yes | 3a | No | No |
| K458 | Hydrogen bond | 2.70 | Yes | Yes | 2 g | No | No | ||
| S469 | Hydrogen bond | 3.08 | Yes | Yes | No | No | No | ||
| P491 | Hydrophobic interaction | 3.98 | Yes | Yes | 3 b | No | No | ||
| 4 | Stavudine | Y453 | Conventional Hydrogen bond | 2.35 | Yes | Yes | 2 g | Yes | No |
| N501* | Conventional Hydrogen bond | 3.05 | Yes | Yes | 3f | Yes | No | ||
| R403* | Carbon Hydrogen bond | 3.30 | Yes | Yes | 1e | No | No | ||
| Y495 | Carbon Hydrogen bond | 3.23 | Yes | Yes | 3f | No | No | ||
| S494 | Carbon Hydrogen bond | 3.30 | Yes | Yes | 3 b | No | No | ||
| 5 | Raltegravir | S349 | Conventional Hydrogen bond | 2.59 | Yes | No | No | No | No |
| S399 | Conventional Hydrogen bond | 2.98 | Yes | No | No | No | No | ||
| S349 | Conventional Hydrogen bond | 2.96 | Yes | No | No | No | No | ||
| F347 | Conventional Hydrogen bond | 2.90 | Yes | No | No | No | No | ||
| L441* | Halogen (Fluorine) | 3.65 | Yes | Yes | 2 g | Yes | No | ||
| N354 | Pi-Donor Hydrogen bond | 2.44 | Yes | No | No | No | No | ||
| A348 | Hydrophobic (alkyl) | 3.54 | Yes | No | No | No | No | ||
| 6 | Zalcitabine | R403* | Carbon Hydrogen bond | 3.30 | Yes | No | 1e | No | No |
| 7 | Favipiravir | R403* | Conventional Hydrogen bond | 3.05 | Yes | No | 1e | No | No |
| Y505 | Conventional Hydrogen bond | 3.30 | Yes | Yes | 3f | Yes | No | ||
| R403* | Carbon Hydrogen bond | 3.40 | Yes | No | 1e | No | No | ||
| 8 | Camostat | L441* | Conventional Hydrogen bond | 2.91 | Yes | Yes | 2 g | No | No |
| N354 | Carbon Hydrogen bond | 3.30 | Yes | No | No | No | No | ||
| 9 | Doxycycline | Y449 | Conventional Hydrogen bond | 1.87 | Yes | Yes | 2 g | Yes | No |
| N501* | Conventional Hydrogen bond | 2.35 | Yes | Yes | 3f | Yes | No | ||
| S494 | Conventional Hydrogen bond | 3.22 | Yes | Yes | 3 b | No | No | ||
| Y505 | Hydrophobic (pi-sigma) | 3.63 | Yes | Yes | 3f | Yes | No | ||
| 10 | Ivermectin | G381 | Conventional Hydrogen bond | 2.32 | Yes | No | No | No | No |
| F377 | Carbon Hydrogen bond | 2.99 | Yes | No | No | No | No | ||
| Y380 | Carbon Hydrogen bond | 3.74 | Yes | No | No | No | No | ||
| C379 | Sulfur-X | 2.99 | Yes | No | No | No | Yes | ||
| Y369 | Pi-Donor Hydrogen bond | 3.28 | Yes | No | No | No | No | ||
RBD = Receptor Binding Domain; RBM = Receptor Binding Motif; ACE-2 = Angiotensin Converting Enzyme type II; * = Possible mutated amino acids in SARS-CoV-2.